Kathryn Litten, PharmD, discussed the pharmacist’s role in helping patients manage metabolic dysfunction-associated steatotic liver disease.
Kathryn Litten, PharmD, BCACP
Advertisement
Kathryn Litten is a clinical assistant professor at the University of Texas at Austin’s College of Pharmacy. She's worked as a clinical pharmacist since 2019 and is a board-certified ambulatory care pharmacist.
Articles by Kathryn Litten, PharmD, BCACP
Kathryn Litten, PharmD, joined Drug Topics to discuss how pharmacists can counsel patients with metabolic dysfunction-associated steatotic liver disease.
Advertisement
Latest Updated Articles
How Pharmacists Can Help Patients Manage MASLD | ASHP MidyearPublished: December 11th 2024 | Updated:
Q&A: Importance of Managing Comorbidities for Patients with MASLD | ASHP MidyearPublished: December 13th 2024 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
American Pharmacists Month: Expanding Services Through Dedicated Pharmacy Clinic
2
Automation Helps Pharmacies Maximize Revenue, Improve Patient Care | NCPA 2025
3
Treatment Strategies for Tardive Dyskinesia
4
Comparing VMAT2 Inhibitors and Formulations
5
